2p15-16.1 microdeletion syndrome
| 2p15-16.1 microdeletion syndrome | |
|---|---|
| |
| Synonyms | |
| Pronounce | |
| Specialty | Medical genetics |
| Symptoms | Intellectual disability, developmental delay, microcephaly, dysmorphic features |
| Complications | N/A |
| Onset | Congenital |
| Duration | Lifelong |
| Types | |
| Causes | Genetic mutation |
| Risks | |
| Diagnosis | Genetic testing, chromosomal microarray analysis |
| Differential diagnosis | Other chromosomal deletion syndromes |
| Prevention | |
| Treatment | Supportive care, therapies for developmental delay |
| Medication | |
| Prognosis | Variable |
| Frequency | Rare |
| Deaths | |

2p15-16.1 microdeletion syndrome is a rare genetic disorder caused by a deletion of a small segment of chromosome 2. This condition is characterized by a variety of clinical features, which can include developmental delay, intellectual disability, and distinctive facial features.
Genetic Basis[edit]
The syndrome is caused by a microdeletion on the short arm of chromosome 2, specifically in the region designated as 2p15-16.1. This deletion results in the loss of several genes, which are believed to contribute to the clinical manifestations of the syndrome. The exact size of the deletion can vary among affected individuals, leading to a range of phenotypic expressions.
Clinical Features[edit]
Individuals with 2p15-16.1 microdeletion syndrome often present with:
- Developmental delay
- Intellectual disability
- Distinctive facial features such as a broad forehead, hypertelorism (wide-set eyes), and a short nose
- Microcephaly (small head size)
- Hypotonia (reduced muscle tone)
Diagnosis[edit]
Diagnosis of 2p15-16.1 microdeletion syndrome is typically made through genetic testing, such as chromosomal microarray analysis or fluorescence in situ hybridization (FISH), which can detect the specific deletion on chromosome 2.
Management[edit]
There is no cure for 2p15-16.1 microdeletion syndrome, and treatment is focused on managing the symptoms and providing supportive care. This may include:
- Early intervention programs for developmental delays
- Special education services
- Physical and occupational therapy
- Regular monitoring by a team of specialists
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

